French pharmaceutical glass manufacturer SGD Pharma is be sold to a European private equity organization.
SGD Pharma’s owners China Jianyin Investment (JIC) are in final negotiations with PAI Partners over the deal.
Christophe Nicoli, Chief Executive Officer of SGD Pharma, says: “By investing in cutting-edge manufacturing technologies, in taking the lead on sustainability and through constantly improving the service level it offers to its clients, the SGD Pharma teams have built a solid platform for performance and growth under JIC’s ownership.
Laurent Rivoire, a Managing Partner at PAI Partners, said: “We look forward to finalizing the acquisition of SGD Pharma from JIC.
“We have closely followed the development of SGD Pharma over the years and have been impressed by the progress made under the leadership of a talented management team.
